Abstract:115 Background. Proliferation of vascular smooth muscle cells (SMCs) within the intima following apoptosis, most likely induced by Fas/Fas-L interaction that corresponds to arterial immune injury, plays an important role in the pathogenesis of accelerated graft arteriosclerosis (AGA). Soluble Fas protein (sFas) is potent inhibitor of apoptosis by blocking the binding of Fas to Fas Ligand. The purpose of this study was to evaluate the effect of gene transfer with sFas on AGA in a rat aortic allograft model. Methods. We constructed a replication-defective adenovirus encoding rat sFas cDNA (AdsFas), and tested the AdsFas inhibition effect on human aorta SMCs and endothelial cells apoptosis in vitro. Sixty-five aorta transplants from DA donors to PVG recipients were performed and divided into five groups. Donor aortic allograft and isografts in situ at time of harvesting was either exposed with saline alone (control); or transfected with 6×109 pfu of adenoviruses encodinging the cDNA for β-galactosidase (Adβ-gal) or empty vector (Ad-null), or soluble Fas (AdsFas) for 20 min. Aortic grafts were collected at 5,30,60 days and evaluated for sFas gene transfer efficiency and morphometry with RT-PCR, immunohistochemistry and computerized microscopy. Results. X-gal staining of the Adβgal transduced allografts showed good protein production in endothelium and adventitia; RT-PCR and immunohistochemistry demonstrated sFas production. At 60 days, the syngeneic aortic grafts displayed very little inflammation with minimal to absent intima lesions. The non-transfected allograft controls showed neointima proliferation and thickening (58.83±10.27 um vs. Syngeneic 8.90±0.70um, P<0.01); with media degeneration and inflammatory adventitia. Similar intima hyperplasia were also found in the allografts transfected with Adenovirus carrying β-Gal (71.67±20.93 um) or Ad-null (69.38±4.68 um) with media disruption, as well as intense inflammation of the adventitia. In contrasts, Intima thickening was significantly reduced in AdsFas transduced grafts (19.50±1.6uM vs. Allograft 5 8.83±10.27um, P<0.01). With sFas, the elastic lamina and thickness of media (91.10±2.80um vs. Allograft 69.16± 11.04um, P<0.05) were well preserved in comparison to other allografts and was similar to Isografts (vs.84.49±1.74um, P>0.05). Conclusions. Gene therapy with soluble-Fas markedly decreases the intima hyperplasia by blocking Fas-mediated apoptosis. Anti-apoptotic gene transfer strategies may provide a new therapeutic approach for transplant arteriosclerosis.

Gene Therapy with Soluble Fas: A Novel Anti-apoptosis Strategy for Transplant Arteriosclerosis

ADENOVIRUS-MEDIATED SOLUBLE FAS GENE TRANSFER SUPRESSES AORTIC ALLOGRAFT ARTERIOSCLEROSIS IN RATS

Gene Therapy with Av3rsfas Inhibits Allograft Arteriosclerosis by Preventing Fas/Fasl Induced Apoptosis in Rat Aorta Transplants.

Induction of lymphocyte apoptosis in rat liver allograft by adenoviral gene transfection of human interleukin-10.

The Effect of FasL Gene Transfer to Islet Cells on Pancreatic Islet Allografts

Utility of adenovirus-mediated Fas ligand and bcl-2 gene transfer to modulate rat liver allograft survival.

Transfusion of Endothelial Cells with Lentivirus-Mediated Expression of Fas Ligand Prolonged Survival of Rat Liver Allograft

Optimization of Adenovirus-Mediated Endothelial Nitric Oxide Synthase Delivery in Rat Hindlimb Ischemia

Therapeutic Effect of Adipose Derived Mesenchymal Stem Cell Transplantation in Reducing Restenosis in a Murine Angioplasty Model

Graft transfected with HO-1 gene inhibiting graft arteriosclerosis in rat aortic transplants

Adenovirus-mediated CTLA4-Ig and FasL Gene Transfer Induces Long-Term Survival of Renal Allografts in Rats

Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy

The Effect of FasL Expression on Pancreatic Islet Allografts.

Adenovirus-mediated Gene Transfer of Tissue Factor Pathway Inhibitor Induces Apoptosis in Vascular Smooth Muscle Cells

Fas Ligand Gene Transfer Enhances the Survival of Tissue-Engineered Chondrocyte Allografts in Mini-Pigs

Gene Therapy for Restenosis

[Study of Adventitial Inflammation and Inflammatory Factors in Pathogenesis of Allograft Arteriosclerosis in Rats].

Fas Ligand Gene Transfer Combined with Low Dose Cyclosporine A Reduces Acute Lung Allograft Rejection.

Perivascular Gene Transfer of Dominant-Negative N19RhoA Attenuates Neointimal Formation Via Inhibition of TGF-β1-Smad2 Signaling in Rats after Carotid Artery Balloon Injury

Adipose-derived Cellular Therapies Prolong Graft Survival in an Allogenic Hind Limb Transplantation Model.

Local transfer of stromal cell-derived factor-1α gene inhibits microsurgical anastomotic thrombosis